Showing 681 - 700 results of 1,061 for search '"lymphoma"', query time: 0.07s Refine Results
  1. 681

    “The Great Mimicker”: An Unusual Etiology of Cytopenia, Diffuse Lymphadenopathy, and Massive Splenomegaly by Mazen Zaarour, Chanudi Weerasinghe, Elias Moussaly, Shafinaz Hussein, Jean-Paul Atallah

    Published 2015-01-01
    “…Sarcoidosis is known as “the great mimicker” (or “the great imitator”) since it exhibits a myriad of symptoms, mimicking other inflammatory, infectious, and neoplastic conditions, including lymphoma. Herein, we report the case of a 44-year-old male patient who was found to have bicytopenia, hypercalcemia, diffuse lymphadenopathy, and massive splenomegaly, a constellation of findings suggestive of underlying lymphoma. …”
    Get full text
    Article
  2. 682

    In Vivo Biodistribution and Lifetime Analysis of Cy5.5-Conjugated Rituximab in Mice Bearing Lymphoid Tumor Xenograft Using Time-Domain Near-Infrared Optical Imaging by Stefania Biffi, Chiara Garrovo, Paolo Macor, Claudio Tripodo, Sonia Zorzet, Erika Secco, Francesco Tedesco, Vito Lorusso

    Published 2008-11-01
    “…In vivo, TD optical imaging analysis of RI-Cy5.5 injected into lymphoma-bearing mice revealed a slow tumor uptake and a specific long-lasting persistence of the probe within the tumor. …”
    Get full text
    Article
  3. 683

    Survival Analysis by Penalized Regression and Matrix Factorization by Yeuntyng Lai, Morihiro Hayashida, Tatsuya Akutsu

    Published 2013-01-01
    “…We tried L1- (lasso), L2- (ridge), and L1-L2 combined (elastic net) penalized regression for diffuse large B-cell lymphoma (DLBCL) patients' microarray data and found that L1-L2 combined method predicts survival best with the smallest logrank P value. …”
    Get full text
    Article
  4. 684

    Endobronchial Infection and Bacterial Lymphadenitis by Gemella morbillorum Leading to Airway Perforation and a Bronchopleural Fistula by Kaitlin N. DePrez, John Ferguson

    Published 2024-01-01
    “…Conclusion: In cases of severe mediastinal adenopathy in a young patient, bacterial lymphadenitis should be considered in the differential diagnosis with lymphoma, germ cell tumor, granulomatosis with polyangiitis, sarcoidosis, histoplasmosis, and inflammatory myofibroblastic tumor.…”
    Get full text
    Article
  5. 685

    HHV-8-Associated Lymphoproliferative Disorders and Pathogenesis in an HIV-Positive Patient by Carlo Guerrero, Tania Jain, Katalin Kelemen

    Published 2019-01-01
    “…The World Health Organization has recently updated the classification of HHV-8-associated LPDs by introducing HHV-8-positive germinotropic LPD (GLPD) in addition to the previously recognized entities of HHV-8-positive diffuse large B-cell lymphoma, not otherwise specified (DLBCL, NOS), primary effusion lymphoma (PEL), and HHV-8-positive multicentric Castleman’s disease (MCD). …”
    Get full text
    Article
  6. 686

    Performance Augmentation of Base Classifiers Using Adaptive Boosting Framework for Medical Datasets by Durr e Nayab, Rehan Ullah Khan, Ali Mustafa Qamar

    Published 2023-01-01
    “…., global cancer map (GCM), lymphoma-I, lymphoma-II, leukaemia, and embryonal tumours. …”
    Get full text
    Article
  7. 687

    Whole-Body 18FDG-PET in an Arthritis Paraneoplastic Syndrome Revealed an Underlying Hematological Neoplasm by Serge Cammilleri, Marie Caroline Guzian, Jean-Pierre Mattei, Olivier Mundler, Sandrine Guis

    Published 2013-01-01
    “…We showed the first image of 18FDG-PET, which leads to a diagnosis of lymphoma in an atypical polyarthritis. About 4% of patients with lymphoma or leukemia suffered from rheumatologic paraneoplastic symptoms like arthralgia and about 10% of the patients with rheumatologic or neurologic clinical symptoms develop a solid cancer or hematological neoplasm. 18FDG-PET is an interesting exam to identify an underlying malignancy when a paraneoplastic syndrome is suspected; it can detect the primitive lesion and/or the metastasis lesions. …”
    Get full text
    Article
  8. 688

    Multimodality imaging of hematologic malignancies affecting the breast: a pictorial essay by Natalia Guerrero-Fajardo, Mane M. Ayala-Duran, Yesika J. Davila-Zablah, Nancy L. Garza-Garcia, Gabriela S. Gomez-Macias, Daniel F. Lopez-Altamirano, Margarita L. Garza-Montemayor

    Published 2024-10-01
    “…Hematologic malignancies affecting the breast are a heterogeneous group that includes lymphomas, leukemias, and multiple myeloma. Secondary infiltration by lymphoma is the most common hematologic malignancy of the breast. …”
    Get full text
    Article
  9. 689

    Is neutropenic fever an obstacle to effective stem cell harvesting? by Semih Başcı, Ersin Bozan, Samet Yaman, Bahar Uncu Ulu, Mehmet Bakırtaş, Tuğçe Nur Yiğenoğlu, Ali Kılınç, Nurgül Özcan, Mehmet Sinan Dal, Merih Kızıl Çakar, Fevzi Altuntaş

    Published 2024-01-01
    “…One hundred and eighty-three patients with the diagnosis of lymphoma or myeloma who underwent chemomobilization between 2015 and 2020 were included in the study. …”
    Get full text
    Article
  10. 690

    Transition of Thyroid Autoantibodies by Rituximab Treatment in Women with Rheumatoid Arthritis by Hüseyin Demirci, Ebru Aydoğan, Bilge Ceydilek

    Published 2024-10-01
    “…Rituximab was first used as a treatment for B-cell malign lymphoma, and it is currently used in the treatment of rheumatoid arthritis. …”
    Get full text
    Article
  11. 691

    Bioinformatics Analysis of miRNAs Targeting TRAF5 in DLBCL Involving in NF-κB Signaling Pathway and Affecting the Apoptosis and Signal Transduction by Chunyao Li, Lanshan Huang, Yongqin Wen, Muhua Yi, Min Gao

    Published 2022-01-01
    “…Diffuse large B-cell lymphoma (DLBCL) is an aggressive B-cell lymphoma with high heterogeneity. …”
    Get full text
    Article
  12. 692

    HHV8/EBV Coinfection Lymphoproliferative Disorder: Rare Entity with a Favorable Outcome by Dhouha Bacha, Beya Chelly, Houda Kilani, Lamia Charfi, Amel Douggaz, Samia Chatti, Emna Chelbi

    Published 2017-01-01
    “…They were negative with common lymphoma-associated markers (CD20, CD3, CD15, CD30, CD10, and bcl2). …”
    Get full text
    Article
  13. 693

    Dextran-Polyacrylamide as Matrices for Creation of Anticancer Nanocomposite by G. Telegeev, N. Kutsevol, V. Chumachenko, A. Naumenko, P. Telegeeva, S. Filipchenko, Yu. Harahuts

    Published 2017-01-01
    “…The polymer nanoparticles loaded with cisplatin at different concentrations from 0.1 to 10 μg/mL yielded dose-dependent decrease in viability of chronic myelogenous leukemia and histiocytic lymphoma cells. The lowest percentage of viable cells was observed for lymphoma cells (22%). …”
    Get full text
    Article
  14. 694

    β2microglobulin levels, clinical and sociodemographic variables in patients with recently diagnosed chronic lymphoproliferative syndrome by Pedro Javier Sánchez Sánchez, Julio Dámaso Fernández Águila, Pedro Sánchez Frenes, María de Jesús Sánchez Bouza, Karelys Díaz Alfonso

    Published 2023-03-01
    “…The series was made up of all adult patients (universe 50) recently diagnosed (without starting specific antitumor therapy) of multiple myeloma, chronic lymphoid leukemia, non-Hodgkin lymphoma and Hodgkin lymphoma, admitted to the Hematology Service of the Dr. …”
    Get full text
    Article
  15. 695

    Disutility Study for Adult Patients with Moderate to Severe Crohn’s Disease by Melany Worbes-Cerezo, Beenish Nafees, Andrew Lloyd, Katy Gallop, Imran Ladha, Cicely Kerr

    Published 2019-03-01
    “…**Results:** The mean TTO value for reference states ‘moderate to severe CD’ and ‘bowel surgery’ were 0.70 (SD=0.28) and 0.69 (SD=0.28). Participants rated lymphoma as the worst AE/surgical complication state (0.44, SD=0.37), followed by tuberculosis (0.47, SD=0.85) and anastomotic leak (0.48, SD=0.38). …”
    Get full text
    Article
  16. 696

    Bcl-2 and Bcl-xL in Diabetes: Contributions to Endocrine Pancreas Viability and Function by Atenea A. Perez-Serna, Daniel Guzman-Llorens, Reinaldo S. Dos Santos, Laura Marroqui

    Published 2025-01-01
    “…Type 1 (T1D) and type 2 diabetes (T2D), the most common forms of diabetes, are characterized by the loss of functional pancreatic β-cells, mostly due to apoptosis. B-cell leukemia/lymphoma 2 (Bcl-2) and B-cell lymphoma-extra large (Bcl-xL), two anti-apoptotic proteins belonging to the Bcl-2 family, are crucial for regulating the intrinsic pathway of apoptosis. …”
    Get full text
    Article
  17. 697

    EBV-Negative Monomorphic B-Cell Posttransplant Lymphoproliferative Disorder with Marked Morphologic Pleomorphism and Pathogenic Mutations in ASXL1, BCOR, CDKN2A, NF1, and TP53 by Agata M. Bogusz

    Published 2017-01-01
    “…This report describes an unusual case of a 33-year-old woman that developed a monomorphic EBV-negative PTLD consistent with diffuse large B-cell lymphoma (DLBCL) 13 years after heart-lung transplant. …”
    Get full text
    Article
  18. 698

    Hepatobiliary Tract and Pancreatic Disorders in Celiac Disease by Hugh J Freeman

    Published 1997-01-01
    “…Finally, celiac disease may be associated with other very rare hepatic complications, such as hepatic T cell lymphoma.…”
    Get full text
    Article
  19. 699

    HIV Infection and the Esophagus by Linda Rabeneck

    Published 1989-01-01
    “…Esophageal ulcers can occur as part of an acute (primary) HIV infection syndrome. ln addition. the esophagus can be involved with the neoplasms associated with acquired immune deficiency syndrome (AIDS) – both Kaposi's sarcoma and non-Hodgkin's lymphoma. Opportunistic infections may also involve the esophagus, most commonly candida and cytomegalovirus infection. …”
    Get full text
    Article
  20. 700

    CLN-978, a novel half-life extended CD19/CD3/HSA-specific T cell-engaging antibody construct with potent activity against B-cell malignancies with low CD19 expression by Agapitos Patakas, Bochong Li, Naveen K Mehta, Kristan Meetze, Patrick A Baeuerle, Jennifer S Michaelson, Hannah M Findlay, Timothy B London

    Published 2023-08-01
    “…An ongoing clinical phase 1 trial is investigating safety, pharmacokinetics, pharmacodynamics, and the initial therapeutic potential of subcutaneously administered CLN-978 in patients with non-Hodgkin’s lymphoma.…”
    Get full text
    Article